Children injected with the Dengvaxia vaccine are in danger of losing financial support from the government due to a clause in the P1.161-billion supplemental budget passed by the Senate, House appropriations committee chair, Davao City Rep. Karlo Nograles, warned on Sunday. Dengvaxia, developed and manufactured by French pharmaceutical giant Sanofi Pasteur, had been blamed for the deaths of dozens of its recipients. ADVERTISEMENTUnlike the House version, he said the supplemental budget approved by the Senate stated that “dengue patients,” instead of “Dengvaxia vaccinees,” might avail of financial assistance for their hospitalization. Nograles cited the case of Rachel Abian, who brought her son to a private hospital after showing symptoms associated with dengue. “This is unfair to her child and the other children who received Dengvaxia because they are forced to take precautions… It’s not right because we have an obligation to these kids,” he said.

Source: Philippine Daily Inquirer September 09, 2018 21:33 UTC